细胞癌中代谢模式的全面分析:对预后和治疗的影响
Yue Wang1, Pengfei Li2, Tao Feng3
1Department of Urology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Frontiers in immunology
|October 3, 2025
概括
研究人员使用多组组分析确定了细胞癌 (RCC) 的三种代谢亚型. 这些亚型与患者的生存,免疫逃避和药物敏感性相关,为个性化RCC治疗铺平了道路.
科学领域:
- 在瘤学瘤学.
- 代谢学 代谢学 代谢学
- 生物信息学是一种生物信息学.
背景情况:
- 细胞癌 (RCC) 呈现出显著的异质性,使预后和治疗复杂化.
- 先进的RCC阶段需要新的分层方法,反映瘤生物学.
研究的目的:
- 通过综合性多种组的方法来识别RCC的代谢亚型.
- 为了将代谢概况与临床结果,免疫特征和药物敏感性相关联.
主要方法:
- 转录和临床数据的综合分析.
- 无监督的聚类用于代谢亚型.
- 不同表达,路径丰富和生存分析.
主要成果:
- 确定了三种不同的代谢亚型 (C1,C2,C3),每个都有独特的生存结果.
- C1表现出增强的氧化酸化和更好的生存率;C2和C3表现出前列腺素/前列腺素生物合成,与预后不佳和免疫逃避有关.
- 发现了对免疫疗法和向药物的亚型特定脆弱性.
结论:
- 代谢亚型为RCC预后和个性化治疗提供了一个框架.
- 在RCC中,代谢重编程会影响瘤免疫力和治疗反应.
- 这种多原子方法支持RCC的精密瘤学应用.
相关概念视频
Cancer Survival Analysis
645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K


